2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Polycythemia Vera
11
Brain Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
9
Glioblastoma
9
Leukemia, Myeloid, Acute
8
Meningioma
7
Head and Neck Neoplasms
7
Gliosarcoma
6
Myelodysplastic Syndromes
4
Glioma
4
Central Nervous System Neoplasms
4
Neoplasms
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Laryngeal Neoplasms
3
Esophageal Neoplasms
3
Treatment-Refractory Solid Tumors
2
Thrombocythemia, Essential
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Primary Myelofibrosis
2
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Hypopharyngeal Neoplasms
2
Interventions
human papillomavirus vaccine, L1 type 16, 18
40
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
32
Papillomavirus Vaccines
24
Human Papillomavirus Recombinant Vaccine nonavalent
12
Vaccines
11
Blood Specimen Collection
10
Data Collection
9
Colposcopy
9
Human Papillomavirus DNA Tests
8
Specimen Handling
7
Radiotherapy, Intensity-Modulated
7
Cisplatin
7
Surveys and Questionnaires
6
Educational Status
6
Early Intervention, Educational
6
Carboplatin
6
Vaginal Smears
5
Vaccines, Synthetic
5
Methods
5
Engerix-B
4
fludarabine
3
epigallocatechin gallate
3
artesunic acid
3
artemisinin
3
Watchful Waiting
3
Polymerase Chain Reaction
3
Patient Navigation
3
Paclitaxel
3
Observation
3
Mass Screening
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Hydroxyurea
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts